Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003861
Filing Date
2024-02-14
Accepted
2024-02-14 21:07:15
Documents
1
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 form4-02152024_020204.html 4  
1 form4-02152024_020204.xml 4 3562
  Complete submission text file 0001415889-24-003861.txt   4997
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 24641754

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)